相关实验视频

Updated: Jan 15, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.0K

在HER2-低与HER2-阳性激素受体阳性乳腺癌中的扩散导向风险分层:多中心回顾分析

Sait Kitapli, Özgür Tanriverdi, İsmail Bayrakci

    Oncology research and treatment
    |January 13, 2026
    PubMed
    概括

    Ki67是激素受体阳性 (HR+) 乳腺癌的关键预后生物标志物,无论HER2状态如何. 对HER2和Ki67的双重评估可以完善风险分层,并确定需要在内分泌治疗之外加强治疗的患者.

    更多相关视频

    Establishing a Competing Risk Regression Nomogram Model for Survival Data04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    10.7K
    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

    Published on: August 1, 2018

    8.4K

    相关概念视频

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
    404